147 related articles for article (PubMed ID: 6185470)
1. Buspirone: chemical profile of a new class of anxioselective agents.
Temple DL; Yevich JP; New JS
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):4-10. PubMed ID: 6185470
[TBL] [Abstract][Full Text] [Related]
2. Notes on buspirone's mechanisms of action.
Garattini S; Caccia S; Mennini T
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):19-24. PubMed ID: 6130069
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology and neurochemistry of buspirone.
Riblet LA; Taylor DP; Eison MS; Stanton HC
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):11-8. PubMed ID: 6130068
[TBL] [Abstract][Full Text] [Related]
4. Buspirone: chemistry, pharmacology, and behavior.
Skolnick P; Paul SM
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):40-4. PubMed ID: 6130072
[TBL] [Abstract][Full Text] [Related]
5. Buspirone, a novel nonbenzodiazepine anxiolytic.
Kastenholz KV; Crismon ML
Clin Pharm; 1984; 3(6):600-7. PubMed ID: 6150781
[TBL] [Abstract][Full Text] [Related]
6. Neuropharmacological profile of buspirone: a non-benzodiazepine anxiolytic with specific mid-brain modulating properties.
Leonard BE
Br J Clin Pract Suppl; 1985 May; 38():74-82. PubMed ID: 2862907
[No Abstract] [Full Text] [Related]
7. Effect of buspirone on prolactin and growth hormone secretion in laboratory rodents and man.
Meltzer HY; Fleming R
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):76-9. PubMed ID: 6130077
[TBL] [Abstract][Full Text] [Related]
8. Effects of buspirone on operant behavior of laboratory rats and cynomolgus monkeys.
Geller I; Hartmann RJ
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):25-33. PubMed ID: 6130070
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological and clinical effects of buspirone.
Taylor DP; Eison MS; Riblet LA; Vandermaelen CP
Pharmacol Biochem Behav; 1985 Oct; 23(4):687-94. PubMed ID: 2866549
[TBL] [Abstract][Full Text] [Related]
10. Buspirone hydrochloride: a unique new anxiolytic agent. Pharmacokinetics, clinical pharmacology, abuse potential and clinical efficacy.
Goldberg HL
Pharmacotherapy; 1984; 4(6):315-24. PubMed ID: 6151170
[TBL] [Abstract][Full Text] [Related]
11. Preclinical pharmacology of buspirone hydrochloride.
Skolnick P; Paul SM; Weissman BA
Pharmacotherapy; 1984; 4(6):308-14. PubMed ID: 6151169
[TBL] [Abstract][Full Text] [Related]
12. Azapirones: history of development.
Eison AS
J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):2S-5S. PubMed ID: 1973936
[TBL] [Abstract][Full Text] [Related]
13. Tolerance to a new class of non-benzodiazepine anxiolytics.
Chodera A; Nowakowska E; Bartczak G
Pol J Pharmacol; 1994; 46(5):479-81. PubMed ID: 7894538
[TBL] [Abstract][Full Text] [Related]
14. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
[TBL] [Abstract][Full Text] [Related]
15. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
[TBL] [Abstract][Full Text] [Related]
16. "Buspirone: a clinical review of a new, non-benzodiazepine anxiolytic".
Uhlenhuth EH
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):109-16. PubMed ID: 6130067
[TBL] [Abstract][Full Text] [Related]
17. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
18. Buspirone analogues. 1. Structure-activity relationships in a series of N-aryl- and heteroarylpiperazine derivatives.
Yevich JP; Temple DL; New JS; Taylor DP; Riblet LA
J Med Chem; 1983 Feb; 26(2):194-203. PubMed ID: 6131130
[TBL] [Abstract][Full Text] [Related]
19. Buspirone attenuates conditioned fear-induced c-Fos expression in the rat hippocampus.
Wisłowska-Stanek A; Zienowicz M; Lehner M; Taracha E; Bidziński A; Maciejak P; Skórzewska A; Szyndler J; Płaźnik A
Neurosci Lett; 2005 Dec; 389(2):115-20. PubMed ID: 16095819
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of the dopamine partial agonist, (+/-)-PD 128483 and its enantiomers.
Meltzer LT; Caprathe BW; Christoffersen CL; Corbin AE; Jaen JC; Ninteman FW; Pugsley TA; Serpa KA; Shih YH; Whetzel SZ
J Pharmacol Exp Ther; 1993 Sep; 266(3):1177-89. PubMed ID: 8103791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
